BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 24660521)

  • 1. An update on vancomycin dosing and monitoring practices in hemodialysis patients.
    Zhang M; Dresser L; Battistella M
    CANNT J; 2013; 23(4):25-7; quiz 28-9. PubMed ID: 24660521
    [No Abstract]   [Full Text] [Related]  

  • 2. Initial vancomycin dosing protocol to achieve therapeutic serum concentrations in patients undergoing hemodialysis.
    Zelenitsky SA; Ariano RE; McCrae ML; Vercaigne LM
    Clin Infect Dis; 2012 Aug; 55(4):527-33. PubMed ID: 22573855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glycopeptides (vancomycin, teicoplanin)].
    Furuta I; Kitahashi T
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():423-6. PubMed ID: 15658354
    [No Abstract]   [Full Text] [Related]  

  • 4. Vancomycin dosing and monitoring.
    Med Lett Drugs Ther; 2009 Apr; 51(1309):25. PubMed ID: 19343006
    [No Abstract]   [Full Text] [Related]  

  • 5. Weight-based versus set dosing of vancomycin for coronary artery bypass grafting or aortic valve surgery.
    Hafermann MJ; Kiser TH; Lyda C; Fish DN; Barber GR; Wempe MF; Cleveland JC
    J Thorac Cardiovasc Surg; 2014 Jun; 147(6):1925-30. PubMed ID: 24521953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of vancomycin when administered during high flux hemodialysis.
    Foote EF; Dreitlein WB; Steward CA; Kapoian T; Walker JA; Sherman RA
    Clin Nephrol; 1998 Jul; 50(1):51-5. PubMed ID: 9710347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urea kinetics and dialysis treatment time predict vancomycin elimination during high-flux hemodialysis.
    Schaedeli F; Uehlinger DE
    Clin Pharmacol Ther; 1998 Jan; 63(1):26-38. PubMed ID: 9465839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic monitoring of intravenous vancomycin in a pediatric critical care unit].
    Villena R; González CA; Nalegach ME; Vásquez A; Villareal M; Drago M
    Rev Chilena Infectol; 2014 Jun; 31(3):249-53. PubMed ID: 25146197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients.
    Eiland LS; English TM; Eiland EH
    Ann Pharmacother; 2011 May; 45(5):582-9. PubMed ID: 21521865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentrations of vancomycin in human bone.
    Borner K; Hahn F; Koeppe P
    J Chemother; 1989 Jul; 1(4 Suppl):588-9. PubMed ID: 16312546
    [No Abstract]   [Full Text] [Related]  

  • 12. Neonatal vancomycin trough level audit using British National Formulary for Children dosing.
    Petrie K; O'Brien C; Bhushan S; Tonna A
    Arch Dis Child Fetal Neonatal Ed; 2015 May; 100(3):F278-9. PubMed ID: 25519438
    [No Abstract]   [Full Text] [Related]  

  • 13. [Level of evidence for therapeutic drug monitoring of vancomycin].
    Jelassi ML; Benlmouden A; Lefeuvre S; Mainardi JL; Billaud EM;
    Therapie; 2011; 66(1):29-37. PubMed ID: 21466775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring.
    Zhao W; Lopez E; Biran V; Durrmeyer X; Fakhoury M; Jacqz-Aigrain E
    Arch Dis Child; 2013 Jun; 98(6):449-53. PubMed ID: 23254142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic drug monitoring of vancomycin in patients receiving haemodialysis: time for a change.
    Fitzpatrick F; McGaley T; Rajan L; Crowley R; Turley M; Humphreys H; Smyth E
    J Clin Pathol; 2006 Jun; 59(6):666-7. PubMed ID: 16731612
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics and tissue penetration of vancomycin continuous infusion as prophylaxis for vascular surgery.
    Payne CJ; Thomson AH; Stearns AT; Watson DG; Zhang T; Kingsmore DB; Byrne DS; Binning AS
    J Antimicrob Chemother; 2011 Nov; 66(11):2624-7. PubMed ID: 21840937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin during the Last Hour of the Hemodialysis Session: A Pharmacokinetic Analysis.
    Ghouti-Terki L; Chasseuil E; Rabot N; Paintaud G; François M; Birmelé B; Darrouzain F; Büchler M; Halimi JM; Ternant D
    Nephron; 2017; 135(4):261-267. PubMed ID: 28152540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin: over 50 years later and still a work in progress.
    Rybak MJ; Rotschafer JC; Rodvold KA
    Pharmacotherapy; 2013 Dec; 33(12):1253-5. PubMed ID: 24302197
    [No Abstract]   [Full Text] [Related]  

  • 19. Initial dosing of vancomycin in critically ill patients.
    Kees MG; Vögeler S; Hilpert JW
    Int J Antimicrob Agents; 2011 Jul; 38(1):91-2. PubMed ID: 21546217
    [No Abstract]   [Full Text] [Related]  

  • 20. Vancomycin serum concentration during febrile neutropenia in patients with acute myeloid leukemia.
    Hochart C; Berthon C; Corm S; Gay J; Cliquennois M; Tricot S; Alfandari S
    Med Mal Infect; 2011 Dec; 41(12):652-6. PubMed ID: 22056376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.